The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Breaking barriers: Effective interventions amplifying minority participation in cancer clinical trials.
 
David Lewis Pottinger
No Relationships to Disclose
 
Regan Gaskin
No Relationships to Disclose
 
Amitkumar Mehta
Stock and Other Ownership Interests - WITTY HEALTH
Consulting or Advisory Role - AstraZeneca; BeiGene; Gilead Sciences; Incyte; Incyte; Kyowa Kirin International; Novartis; Pharmacyclics; Roche/Genentech; Seagen; TG Therapeutics
Speakers' Bureau - Adaptive Biotechnologies; BeiGene; Epizyme; Gilead Sciences; Incyte; Kite, a Gilead company; Kyowa Kirin International; Seagen
Research Funding - ADC Therapeutics (Inst); ADC Therapeutics (Inst); Affimed Therapeutics (Inst); Aileron Therapeutics (Inst); Artiva (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Fate Therapeutics (Inst); Forty Seven (Inst); Gilead Sciences (Inst); I-Mab (Inst); incyte (Inst); Innate Pharma (Inst); Juno Therapeutics (Inst); Merck (Inst); Ono Pharmaceutical (Inst); Pharmacyclics/Janssen (Inst); Roche/Genentech (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics (Inst); TG Therapeutics (Inst)
 
Mona N. Fouad
No Relationships to Disclose
 
Soumya J. Niranjan
No Relationships to Disclose
 
Aakash Desai
Consulting or Advisory Role - Amgen; Foundation Medicine; Sanofi